ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,291.34
0.15%
Dow Jones
38,711.29
0.36%
US Dollar vs MXN
17.63228
-1.03%
Brent Oil
77.69
0.75%
Bitcoin
70,730.97
0.15%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
05/06/202406:05GlobeNewswire Inc.Fortuna Announces Offering of Convertible Senior NotesTSX:FVIFortuna Silver Mines Inc
05/06/202406:05Business WireHyperscience Accelerates Momentum with Record Q1 2024 Results, Stellar Customer Retention Rates, and Market Leadership Accolades
05/06/202406:05GlobeNewswire Inc.Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of ShareholdersTSX:ELDEldorado Gold Corporation
05/06/202406:05Business WireTeledyne FLIR Airborne Imaging Systems Bring New Perspective to Storytelling in Paramount+'s Summer Hit Series, CHOPPER COPSNYSE:TDYTeledyne Technologies Inc
05/06/202406:05PR Newswire (US)REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:RGNXREGENXBIO Inc
05/06/202406:05GlobeNewswire Inc.Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development OfficerNASDAQ:YMABY mAbs Therapeutics Inc
05/06/202406:04Edgar (US Regulatory)Form 8-K - Current reportNYSE:UNFIUnited Natural Foods Inc
05/06/202406:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:SHOPShopify Inc
05/06/202406:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:VNTVontier Corporation
05/06/202406:04PR Newswire (US)Temporary Wall Systems celebrates new location in the Puget Sound region of Washington State
05/06/202406:03Alliance NewsAlliance NewsLONDON MARKET MIDDAY: European blue-chips up ahead of likely rate cuts
05/06/202406:03PR Newswire (US)White Castle spices up summer with two limited time only, all white meat Chicken Ring flavors at an appetizing deal of 12 for $3.99
05/06/202406:03PR Newswire (US)Brooklyn HVAC experts say eco-friendly refrigerants will change the future of cooling
05/06/202406:02Business WireGlobal Blue Reports a Strong Operational Performance With Improved Financial Position and Stengthened Balance SheetNYSE:GBGlobal Blue Group Holding AG
05/06/202406:02Business WireSilfab Solar Modules Earn “Top Performer” Rating From Kiwa PVEL for Long-Term Reliability, Performance
05/06/202406:02PR Newswire (US)Garmin celebrates Global Running Day with a look at the positive health benefits of runningNYSE:GRMNGarmin Ltd
05/06/202406:02PR Newswire (Canada)LE FPI PRO ANNONCE LE RÉSULTAT DU VOTE TENU À L'ASSEMBLÉE ANNUELLE DES PORTEURS DE PARTS DE 2024TSX:PRV.UNPro Real Estate Investment Trust
05/06/202406:02PR Newswire (Canada)PROREIT ANNOUNCES VOTING RESULTS FROM 2024 ANNUAL MEETING OF UNITHOLDERSTSX:PRV.UNPro Real Estate Investment Trust
05/06/202406:01Business WirePrecision BioSciences Presents New Preclinical Safety Data for PBGENE-HBV Clinical Candidate at the European Association for the Study of the Liver CongressNASDAQ:DTILPrecision BioSciences Inc
05/06/202406:01GlobeNewswire Inc.Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024NASDAQ:OCEAOcean Biomedical Inc
05/06/202406:01GlobeNewswire Inc.SummerSeries in Trillium Park Returns at Ontario Place
05/06/202406:00GlobeNewswire Inc.SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
05/06/202406:00GlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
05/06/202406:00GlobeNewswire Inc.AutoZone Vendor Summit Recognizes Contributions of Top SuppliersNYSE:AZOAutoZone Inc
05/06/202406:00GlobeNewswire Inc.Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade from B to B+BBD-A
05/06/202406:00GlobeNewswire Inc.Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying Potential and Differentiated Therapeutic Profile of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)NASDAQ:ALTAltimmune Inc
05/06/202406:00GlobeNewswire Inc.ArriVent Announces a Multi-Target ADC Collaboration with AlphamabNASDAQ:AVBPArriVent BioPharma Inc
05/06/202406:00GlobeNewswire Inc.Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
05/06/202406:00GlobeNewswire Inc.PyroGenesis Clears Final Requirement to Becoming Approved Titanium Powder Supplier to Global Aerospace OEM Client8PY
05/06/202406:00Business WirePolestar Reduces Supply Chain Emissions Through Integration of Renewable Fuels for Ocean FreightNASDAQ:PSNYPolestar Automotive Holding UK PLC

Su Consulta Reciente

EU
BQPAH
Banque Postale Home Loan...
BIT
P1Y029
NLBNPIT1Y029 20240621 31...
BOV
BRAP3M
BRADESPAR ON
TG
AA2
AMADA
EU
F132S
F132S
BIT
IEMB
Exchange Traded Funds
BOV
S2UI34R
Sun Communities
TG
IXX
init innovation in traff...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados